0
     

Report Added
Report already added
Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity

Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity

Global onychomycosis treatment market will reach $5,787.4 million by 2031, growing by 7.9% annually over 2021-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.
Highlighted with 80 tables and 72 figures, this 150-page report “Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Region.

Based on Onychomycosis Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Distal Subungual Onychomycosis
•White Superficial Onychomycosis
•Proximal Subungual Onychomycosis
•Candidal Onychomycosis
•Other Onychomycosis Types

Based on Treatment Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Drug Treatment
•Laser Therapy
•Photodynamic Therapy
•Other Therapies

By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Hospitals and Clinics
•Online Stores
•Retail Pharmacies
•Other Distribution Channels

Geographically, the following regions together with the listed national/local markets are fully investigated:
•North America (U.S., Canada, and Mexico)
•Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•South America (Brazil, Chile, Argentina, Rest of South America)
•MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction9
1.1 Industry Definition and Research Scope9
1.1.1 Industry Definition9
1.1.2 Research Scope10
1.2 Research Methodology13
1.2.1 Overview of Market Research Methodology13
1.2.2 Market Assumption14
1.2.3 Secondary Data14
1.2.4 Primary Data14
1.2.5 Data Filtration and Model Design15
1.2.6 Market Size/Share Estimation16
1.2.7 Research Limitations17
1.3 Executive Summary18
2 Market Overview and Dynamics20
2.1 Market Size and Forecast20
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market23
2.2 Major Growth Drivers25
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of Global Market by Onychomycosis Type43
3.1 Market Overview by Onychomycosis Type43
3.2 Distal Subungual Onychomycosis45
3.3 White Superficial Onychomycosis46
3.4 Proximal Subungual Onychomycosis47
3.5 Candidal Onychomycosis48
3.6 Other Onychomycosis Types49
4 Segmentation of Global Market by Treatment Type50
4.1 Market Overview by Treatment Type50
4.2 Drug Treatment52
4.3 Laser Therapy53
4.4 Photodynamic Therapy54
4.5 Other Therapies55
5 Segmentation of Global Market by Distribution Channel56
5.1 Market Overview by Distribution Channel56
5.2 Hospitals and Clinics58
5.3 Online Stores59
5.4 Retail Pharmacies60
5.5 Other Distribution Channels61
6 Segmentation of Global Market by Region62
6.1 Geographic Market Overview 2021-203162
6.2 North America Market 2021-2031 by Country66
6.2.1 Overview of North America Market66
6.2.2 U.S.70
6.2.3 Canada73
6.2.4 Mexico75
6.3 European Market 2021-2031 by Country77
6.3.1 Overview of European Market77
6.3.2 Germany81
6.3.3 U.K.83
6.3.4 France85
6.3.5 Spain87
6.3.6 Italy89
6.3.7 Netherlands91
6.3.8 Rest of European Market93
6.4 Asia-Pacific Market 2021-2031 by Country95
6.4.1 Overview of Asia-Pacific Market95
6.4.2 Japan99
6.4.3 China102
6.4.4 Australia104
6.4.5 India106
6.4.6 South Korea108
6.4.7 Rest of APAC Region110
6.5 South America Market 2021-2031 by Country112
6.5.1 Argentina115
6.5.2 Brazil117
6.5.3 Chile119
6.5.4 Rest of South America Market121
6.6 MEA Market 2021-2031 by Country122
6.6.1 UAE125
6.6.2 Saudi Arabia127
6.6.3 South Africa129
6.6.4 Other National Markets131
7 Competitive Landscape132
7.1 Overview of Key Vendors132
7.2 New Product Launch, Partnership, Investment, and M&A135
7.3 Company Profiles136
Bausch Health Companies Inc.136
Bayer AG138
Cipla Ltd139
Dr. Reddys Laboratories Ltd140
Galderma SA141
GlaxoSmithKline PLC142
Johnson & Johnson143
Lumenis Ltd144
Medimetriks Pharmaceuticals Inc.145
Moberg Pharma AB146
Novartis AG147
Pfizer Inc.148
Sanofi SA149
RELATED REPORTS150

List of Tables:

Table 1. Snapshot of Global Onychomycosis Treatment Market in Balanced Perspective, 2021-203119
Table 2. World Economic Outlook, 2021-203122
Table 3. Clinical Trials of Onychomycosis Treatment28
Table 4. World Health Spending by Region, $ bn, 2013-202031
Table 5. Main Product Trends and Market Opportunities in Global Onychomycosis Treatment Market35
Table 6. Global Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn43
Table 7. Global Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn50
Table 8. Global Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn56
Table 9. Global Onychomycosis Treatment Market by Region, 2021-2031, $ mn63
Table 10. Leading National Onychomycosis Treatment Market, 2021 and 2031, $ mn65
Table 11. North America Onychomycosis Treatment Market by Country, 2021-2031, $ mn68
Table 12. U.S. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn72
Table 13. U.S. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn72
Table 14. U.S. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn72
Table 15. Canada Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn74
Table 16. Canada Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn74
Table 17. Canada Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn74
Table 18. Mexico Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn76
Table 19. Mexico Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn76
Table 20. Mexico Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn76
Table 21. Europe Onychomycosis Treatment Market by Country, 2021-2031, $ mn80
Table 22. Germany Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn82
Table 23. Germany Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn82
Table 24. Germany Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn82
Table 25. U.K. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn84
Table 26. U.K. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn84
Table 27. U.K. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn84
Table 28. France Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn86
Table 29. France Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn86
Table 30. France Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn86
Table 31. Spain Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn88
Table 32. Spain Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn88
Table 33. Spain Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn88
Table 34. Italy Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn90
Table 35. Italy Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn90
Table 36. Italy Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn90
Table 37. Netherlands Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn92
Table 38. Netherlands Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn92
Table 39. Netherlands Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn92
Table 40. Onychomycosis Treatment Market in Rest of Europe by Country, 2021-2031, $ mn94
Table 41. APAC Onychomycosis Treatment Market by Country, 2021-2031, $ mn97
Table 42. Japan Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn101
Table 43. Japan Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn101
Table 44. Japan Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn101
Table 45. China Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn103
Table 46. China Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn103
Table 47. China Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn103
Table 48. Australia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn105
Table 49. Australia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn105
Table 50. Australia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn105
Table 51. India Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn107
Table 52. India Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn107
Table 53. India Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn107
Table 54. South Korea Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn109
Table 55. South Korea Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn109
Table 56. South Korea Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn109
Table 57. Onychomycosis Treatment Market in Rest of APAC by Country/Region, 2021-2031, $ mn111
Table 58. South America Onychomycosis Treatment Market by Country, 2021-2031, $ mn114
Table 59. Argentina Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn116
Table 60. Argentina Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn116
Table 61. Argentina Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn116
Table 62. Brazil Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn118
Table 63. Brazil Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn118
Table 64. Brazil Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn118
Table 65. Chile Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn120
Table 66. Chile Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn120
Table 67. Chile Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn120
Table 68. MEA Onychomycosis Treatment Market by Country, 2021-2031, $ mn124
Table 69. UAE Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn126
Table 70. UAE Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn126
Table 71. UAE Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn126
Table 72. Saudi Arabia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn128
Table 73. Saudi Arabia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn128
Table 74. Saudi Arabia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn128
Table 75. South Africa Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn130
Table 76. South Africa Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn130
Table 77. South Africa Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn130
Table 78. Bausch Health Companies Inc.: Company Snapshot136
Table 79. Bausch Health Companies Inc.: Business Segmentation137
Table 80. Bausch Health Companies Inc.: Product Portfolio137

Report Title: Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity